"Eli Lilly and Company (NYSE: LLY) announced today it has received approval from the FDA to market Reconcile(TM) (fluoxetine hydrochloride), the first selective erotonin reuptake inhibitor (SSRI) class of antidepressants approved by the FDA for treatment of canine separation anxiety in conjunction with behavior modification training. Reconcile(TM) is the first Lilly product approved by the FDA for dogs and is now available to U.S. veterinarians."
And why would we give prozac to dogs?
"Reconcile(TM) allows dogs to be more receptive to your training to help with anxiety. Canine separation anxiety is a prevalent and often misunderstood behavior problem, according to Connell. It amounts to undesirable behavior that occurs when the dog is left alone even for short periods of time. The resulting anxiety may cause the dog to engage in inappropriate behavior, such as destruction, excess vocalization and inappropriate elimination. Anorexia and depression also may be observed in some cases. "Your family veterinarian may recommend certain tests before diagnosing separation anxiety," Connell added. "Such tests are used to rule out other potential physiological causes of inappropriate behavior."For dogs affected by separation anxiety, Reconcile(TM) reduces inappropriate behaviors, minimizes the pet's distress and increases receptivity to a simple training plan called the BOND(TM) modification training plan."
That's right, the drug manufacturers have also bundled a doggie behavior modification program to go along with their prozac. I'm still in shock at the marketing genius/evilness.
No comments:
Post a Comment